Sofia, Bulgaria, September 23, 2021 – According to the requirements of Art. 100t of LPOS, “Sopharma” AD notifies that on the basis of Art. 187b of the Commercial Law and Art. 111 para. 5 and para. 6 of LPOS and in connection with a decision of the General Meeting of the company held on February 23, 2018 and a decision of the Board of Directors of September 23, 2021, “Sopharma” AD notifies that the company intends to buy its own shares in the restriction under Art. 111 para. 5 of LPOS, as follows: